Skip to content

POINT - Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain

Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05828121
Acronym
POINT
Enrollment
90
Registered
2023-04-25
Start date
2022-10-01
Completion date
2025-06-01
Last updated
2023-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Opioid Use

Brief summary

The investigators do research on chronic pain treatment to minimize the risks associated with opioids.

Detailed description

The investigators know that patients suffering from chronic pain need good treatment. The use of opioids for chronic, non-cancer related pain may seem appropriate in the short term, but can often have negative consequences for both the individual and society in the long term. Several factors-the escalating use of opioids to chronic pain patients, the increasing use of strong opioids in particular, and the increasing number of overdoses caused by prescription opioids-point to the start of an opioid epidemic in Norway. Objectives The overall goal of the POINT project is to provide knowledge to optimize treatment of patients with chronic pain in order to avoid unnecessary escalation of opioid treatment, improve their quality of life and reduce the burden of disease. In the long run our objective is to prevent the unwanted consequences of opioid treatment and improve patients' quality of life. Ultimately, through this project the investigators hope to prevent an opioid epidemic in Norway. To achieve the main goal, the investigators will focus on pain patients and their doctors, as increasing opioid use may occur through the patient-doctor interaction. Methods The project will develop and test a non-drug interventions that consist of an interdisciplinary group treatment . Financing The Research Council of Norway Cooperation St. Olavs Hospital Stavanger Hospital Trust City of Stavanger National Institute of Public Health (FHI) Alcohol and Drug Research Western Norway (KoRFor) Foreningen for kroniske smertepasienter (FKS) Norwegian Forum of Disabled Peoples' Organizations (SAFO) Cooperation with other projects Injury Prevention and Outcomes following Trauma

Interventions

BEHAVIORALPOINT1

Receiving treatment

Sponsors

The Research Council of Norway
CollaboratorOTHER
Helse Stavanger HF
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

MRC framework for a complex intervention

Eligibility

Sex/Gender
ALL
Age
18 Years to 67 Years
Healthy volunteers
No

Inclusion criteria

* non-malignant, chronic pain * Registered in Stavanger municipality * Consent to participation. * Age 18 - 67 years * Pain duration \<10 years

Exclusion criteria

* malignant pain condition

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Audit C at 12 Weeks12 weeksAudit C
Change from baseline in Pain Scores on the Visual Analog Scale at 12 Weeks12 weeksVisual Analog Scale
Change from baseline in Bergen Insomnia scale at 12 Weeks12 weeksBIS
Change from baseline in Health-related quality of life at 12 Weeks12 weeksHQ5D5L

Countries

Norway

Contacts

Primary ContactKine Gjesdal, PhD
kine.gjesdal@sus.no004748136702

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026